Search

Displaying results 701 - 710 of 10000 in total
  1. Drug

    Acetylcysteine

    go.drugbank.com/drugs/DB06151
    ApprovedInvestigational

    [A228158,A228163,A228168] Acetylcysteine was granted FDA approval on 14 September 1963.[L31488] … Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy and the treatment of [acetaminophen] overdose.

    Mixtures: AMINOPLASMAL-5% E INFUSION, AMINOPLASMAL-10% E INFUSIONCategories: Compounds used in a research, industrial, or household setting
  2. Pathway

    Brexanolone Action Pathway

    smpdb.ca/view/SMP0126148
    Drug action

    Brexanolone is a neuroactive steroid that occurs naturally (referred to as natural allopregnanolone) in the body when the female sex hormone progesterone is metabolized. … In the liver, progesterone is metabolized to 5-alpha-dihydroprogesterone (5-alpha-DHP) via 5-alpha-reductase, which is then further metabolized by 3-alpha-hydroxysteroid-dehydrogenase (3-alpha-HSD) to

    Drugs: Pyridoxal phosphate · Glutamic acid · ATP · Progesterone · Calcium · Magnesium cation +4 more
  3. Drug

    Nafarelin

    go.drugbank.com/drugs/DB00666
    ApprovedInvestigational

    Nafarelin has been used in the treatments of central precocious puberty and endometriosis.

  4. Drug

    Poliovirus type 2 antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB10796
    ApprovedInvestigational

    The vaccine contains purified and inactivated poliovirus type 2 that were grown from a continuous line of monkey kidney cells. … Poliovirus type 2 antigen is a suspension of poliovirus Type 2 (MEF-1) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis

    Mixtures: VeroPol Injektionslösung in einer Fertigspritze, -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
  5. Drug

    Proline

    go.drugbank.com/drugs/DB00172
    ApprovedInvestigationalNutraceutical

    Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. … Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins.

    Mixtures: POLİNUTHREE EN-550 ELEKTROLİTLİ AMİNOASİT ÇÖZELTİSİ, GLUKOZ ÇÖZELTİSİ, VE LİPİD EMÜLSİYONU, 1000 ML, POLİNUTHREE EN-550 ELEKTROLİTLİ AMİNOASİT ÇÖZELTİSİ, GLUKOZ ÇÖZELTİSİ, VE LİPİD EMÜLSİYONU, 1500 ML
  6. Indication

    Moderate to Severe Glabellar Frown Lines

    go.drugbank.com/conditions/DBCOND0042188
    Drugs: LetibotulinumtoxinA · TrenibotulinumtoxinE
    Synonyms: Moderate to Severe Glabellar Line
  7. Drug

    Ipilimumab

    go.drugbank.com/drugs/DB06186
    ApprovedInvestigational

    [L12126] Ipilimumab was granted FDA approval on 25 March 2011.[L12126] … [L12126] Blocking CTLA-4 removes an inhibitory signal from reducing the activity of T lymphocytes.[A35065,A35080,L12126] Ipilimumab was developed by Bristol-Myers Squibb and Medarex.

  8. Drug

    Magnesium

    go.drugbank.com/drugs/DB14513
    ApprovedInvestigational

    [A19349] The element can be found in abundance in the hydrosphere and in mineral salts such as dolomite and magnesium carbonate. … Magnesium is classified as an alkaline earth metal and has 2 hydration shells.

    Mixtures: Ez-flex, Cavan-EC SOD DHAProducts: EMGE 300MG PULV Z.HER E LO, MAGNEROT CLASSIC N
  9. Drug

    Sodium fluorophosphate

    go.drugbank.com/drugs/DB09484
    ApprovedInvestigational

    Sodium monofluorophosphate is used in OTC dental preparations to help protect against cavities.

    Mixtures: Hawaiian Airline EC with Colgate Toothbrush and Sun, Exoden All In OneCategories: Compounds used in a research, industrial, or household setting
  10. Drug

    Donepezil

    go.drugbank.com/drugs/DB00843
    ApprovedInvestigational

    Donepezil was first approved by the FDA in 1996, and its extended-release form was approved in combination with [Memantine] in 2014 to manage moderate and severe forms of Alzheimer's dementia. … In 2016, the global burden of dementia was estimated to be 43.8 million, demonstrating a significant increase from a global prevalence of 20.2 million in 1990.

    Products: DONEPEZIL EG